Onetime investors’ pet stock Freshpet (NASDAQ: FRPT) wasn’t such a good boy over the past few days. On the back of a recommendation downgrade from one analyst and price target cuts from two others, investors sold out of the stock in recent trading sessions. That left it with a nearly 11% decline in price week-to-date as of Thursday evening, according to data compiled by S&P Global Market Intelligence.
Of the three events, the most consequential was the downgrade. This occurred on Tuesday when Oppenheimer‘s Rupesh Parikh moved his Freshpet recommendation down one peg to perform (hold, in other words) from his former outperform (buy). In doing so, Parikh removed his $140 per share price target; it has not yet been replaced.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
According to reports, the analyst’s new take on Freshpet is based on his observation that management has sounded more subdued about the company’s prospects. He also characterized the company’s latest guidance as “disappointing” and wrote that investors would be wise to wait for signs of top-line improvements.
This was compounded by those twin price target cuts, both of which were enacted at the beginning of the week.
Of the two, the more drastic was made by JPMorgan Chase prognosticator Ken Goldman, who now feels that Freshpet is fairly valued at $102 per share rather than his previous price target of $154. His peer Mark Astrachan of Stifel lowered his to $135 per share from $155. Both men kept their existing recommendations on the stock intact; these were neutral and buy, respectively.
I wouldn’t necessarily bail from Freshpet, even though the stock has been in the investor doghouse since publishing its fourth-quarter and full-year results in February. I think its business strategy centered on healthy food products for our four-legged friends is a solid one, and the company is proving that it can grow its business robustly. This might be a good “buy on weakness” candidate.
Before you buy stock in Freshpet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Freshpet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $709,381!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of March 10, 2025
JPMorgan Chase is an advertising partner of Motley Fool Money. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Freshpet and JPMorgan Chase. The Motley Fool has a disclosure policy.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact legal@gsix.org
